BUY Cipla Ltd. — IDBI Capital
byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·21 Sept · today
Wockhardt Share Price Today: 2.19% rise and sector view
NewsGoogle News·17 Sept · 4d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Prakash Gaba4 Nov 2026 · Same day · target ₹1,410 · Expired
- BUY — Kush Bohra3 Nov 2026 · Same day · target ₹1,415 · Expired
- BUY — Rakesh Bansal2 Nov 2026 · Same day · target ₹1,407 · Expired
- BUY — Kunal Bothra2 Nov 2026 · ~2 weeks · target ₹1,420 · Active
- BUY — Siddharth Rai Mangala30 Oct 2026 · Same day · target ₹1,395 · Expired
More from IDBI Capital
- BUY Alkem Laboratories6 Nov 2026 · ~2 weeks · target ₹5,460 · Active
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,735 · Active
- BUY Sun Pharmaceutical Industries6 Nov 2026 · ~2 weeks · target ₹1,925 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,575 · Active
- BUY Rolex Rings6 Nov 2026 · ~1 year · target ₹241 · Active

